Report cover image

Global Sepsis Diagnostics Market Size- By Product, By Technology, By Method Type, By Pathogen Type, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jul 02, 2025
Length 259 Pages
SKU # SPER20295386

Description

Sepsis Diagnostics Market Introduction and Overview

According to SPER Market Research, ‘Global Sepsis Diagnostics Market Size- By Product, By Technology, By Method Type, By Pathogen Type, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ the Global Sepsis Diagnostics Market is estimated to reach USD 1498.27 million by 2034 with a CAGR of 7.63%.

Sepsis diagnostics refer to the methods and technologies used to detect sepsis, a serious medical condition caused by the body’s overwhelming response to infection, often leading to tissue damage and organ failure. Early and precise identification is essential to prevent complications and improve patient outcomes. These diagnostic approaches may include blood tests, molecular assays, biomarker detection, and rapid point-of-care tools that help determine the presence and origin of infection.

Restraints:
Although the sepsis diagnostics market shows promise, it encounters major challenges. The expensive nature of advanced molecular devices, automated analyzers, and quick assay kits restricts their availability, particularly in low- and middle-income nations with limited financial resources. Additionally, a shortage of trained laboratory staff complicates accurate test administration and interpretation.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered

By Product, By Technology, By Method Type, By Pathogen Type, By End-User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbott Laboratories, BioMérieux SA, Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter Inc, T2 Biosystems Inc, Nanosphere Inc, Hoffmann-La Roche Ltd, Danaher Corporation.

Global Sepsis Diagnostics Market Segmentation:

By Product:
Based on the Product, Global Sepsis Diagnostics Market is segmented as; Blood culture media, Instruments, Assay kits & reagents, Software.

By Technology: Based on the Technology, Global Sepsis Diagnostics Market is segmented as; Microbiology, Molecular diagnostics, Immunoassays, Flow cytometry.

By Method Type: Based on the Method Type, Global Sepsis Diagnostics Market is segmented as; Conventional diagnostics, Automated diagnostics.

By Pathogen Type: Based on the Pathogen Type, Global Sepsis Diagnostics Market is segmented as; Bacterial sepsis, Fungal sepsis, Others.

By End-User: Based on the End-User, Global Sepsis Diagnostics Market is segmented as; Hospitals, Diagnostic centres, Clinics, Others.

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

259 Pages
1. Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPERs internal database
2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Sepsis Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Sepsis Diagnostics Market
7.Global Sepsis Diagnostics Market, By Product (USD Million) 2021-2034
7.1.Blood culture media
7.2.Instruments
7.3.Assay kits & reagents
7.4.Software
8.Global Sepsis Diagnostics Market, By Technology (USD Million) 2021-2034
8.1.Microbiology
8.2.Molecular diagnostics
8.3.Immunoassays
8.4.Flow cytometry
9.Global Sepsis Diagnostics Market, By Method Type (USD Million) 2021-2034
9.1.Conventional diagnostics
9.2.Automated diagnostics
10.Global Sepsis Diagnostics Market, By Pathogen Type (USD Million) 2021-2034
10.1.Bacterial sepsis
10.2.Fungal sepsis
10.3.Others
11.Global Sepsis Diagnostics Market, By End-User (USD Million) 2021-2034
11.1.Hospitals
11.2.Diagnostic centres
11.3.Clinics
11.4.Others
12.Global Sepsis Diagnostics Market, (USD Million) 2021-2034
12.1.Global Sepsis Diagnostics Market Size and Market Share
13.Global Sepsis Diagnostics Market, By Region, (USD Million) 2021-2034
13.1.Asia-Pacific
13.1.1.Australia
13.1.2.China
13.1.3.India
13.1.4.Japan
13.1.5.South Korea
13.1.6.Rest of Asia-Pacific
13.2.Europe
13.2.1.France
13.2.2.Germany
13.2.3.Italy
13.2.4.Spain
13.2.5.United Kingdom
13.2.6.Rest of Europe
13.3.Middle East and Africa
13.3.1.Kingdom of Saudi Arabia
13.3.2.United Arab Emirates
13.3.3.Qatar
13.3.4.South Africa
13.3.5.Egypt
13.3.6.Morocco
13.3.7.Nigeria
13.3.8.Rest of Middle-East and Africa
13.4.North America
13.4.1.Canada
13.4.2.Mexico
13.4.3.United States
13.5.Latin America
13.5.1.Argentina
13.5.2.Brazil
13.5.3.Rest of Latin America
14.Company Profile
14.1.Abbott Laboratories
14.1.1.Company details
14.1.2.Financial outlook
14.1.3.Product summary
14.1.4.Recent developments
14.2.BioMerieux SA
14.2.1.Company details
14.2.2.Financial outlook
14.2.3.Product summary
14.2.4.Recent developments
14.3.Thermo Fisher Scientific Inc
14.3.1.Company details
14.3.2.Financial outlook
14.3.3.Product summary
14.3.4.Recent developments
14.4.Becton, Dickinson, and Company
14.4.1.Company details
14.4.2.Financial outlook
14.4.3.Product summary
14.4.4.Recent developments
14.5.Bruker Corporation
14.5.1.Company details
14.5.2.Financial outlook
14.5.3.Product summary
14.5.4.Recent developments
14.6.Beckman Coulter, Inc
14.6.1.Company details
14.6.2.Financial outlook
14.6.3.Product summary
14.6.4.Recent developments
14.7.Danaher Corporation
14.7.1.Company details
14.7.2.Financial outlook
14.7.3.Product summary
14.7.4.Recent developments
14.8.Hoffmann-LA Roche Ltd
14.8.1.Company details
14.8.2.Financial outlook
14.8.3.Product summary
14.8.4.Recent developments
14.9.Nanosphere, Inc
14.9.1.Company details
14.9.2.Financial outlook
14.9.3.Product summary
14.9.4.Recent developments
14.10.T2 Biosystems, Inc
14.10.1.Company details
14.10.2.Financial outlook
14.10.3.Product summary
14.10.4.Recent developments
14.11.Others
15.Conclusion
16.List of Abbreviations
17.Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.